Collab Z Inc.
CLBZAnalytical Summary
Collab Z Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.
7-Year Financial Trajectory
QuarterlyBullish Indicators
- No bullish signals detected.
Bearish Risks
- Operating Margin (%)Operating Margin (%) is in the bottom quartile
- Profit Margin (%)Profit Margin (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q2 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Dec 31, 2025 10-Q ↗ | Q4 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2024 10-Q ↗ | Q4 FY2024 Sep 30, 2024 10-K ↗ | Q4 FY2023 Sep 30, 2023 10-K ↗ |
|---|---|---|---|---|---|---|---|
| Revenue Growth YoY (%) |
105.9%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+2018%)
|
12.4%
Good
Good
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+148%)
|
— | — | — | — | — |
| EPS Growth YoY (%) |
200.0%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
-50.0%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — | — | — |
| Net Income Growth YoY (%) |
-16.4%
Weak
Weak
Year-over-year change in net income |
-16.4%
Weak
Weak
Year-over-year change in net income |
— | — | — | — | — |
| FCF Growth YoY (%) |
-22.6%
Weak
Weak
Year-over-year change in free cash flow |
N/M | — | — | — | — | — |
| Metric | Q2 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Dec 31, 2025 10-Q ↗ | Q4 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2024 10-Q ↗ | Q4 FY2024 Sep 30, 2024 10-K ↗ | Q4 FY2023 Sep 30, 2023 10-K ↗ |
|---|---|---|---|---|---|---|---|
| Operating Margin (%) (%) |
23.3%
Good
↑
Good
Improving
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-22%)
|
17.4%
Fair
→
Fair
Stable
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-42%)
|
— |
6.5%
Caution
Caution
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-78%)
|
28.1%
Excellent
Excellent
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-6%)
|
— | — |
| Profit Margin (%) (%) |
12.2%
Fair
↓
Fair
Declining
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-51%)
|
19.6%
Good
↓
Good
Declining
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-22%)
|
— |
30.0%
Excellent
Excellent
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Above avg (+20%)
|
26.4%
Excellent
Excellent
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Above avg (+5%)
|
— | — |
| FCF Margin (%) (%) |
-14.6%
Weak
↑
Weak
Improving
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
-32.6%
Weak
↓
Weak
Declining
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— |
-24.5%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
51.5%
Excellent
Excellent
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— | — |
| FCF / Net Income (x) |
-1.20x
Weak
→
Weak
Stable
Free cash flow relative to reported net income
Optimal:
> 1x
|
-1.66x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
-0.82x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.95x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
| Metric | Q2 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Dec 31, 2025 10-Q ↗ | Q4 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2024 10-Q ↗ | Q4 FY2024 Sep 30, 2024 10-K ↗ | Q4 FY2023 Sep 30, 2023 10-K ↗ |
|---|---|---|---|---|---|---|---|
| Return on Invested Capital (%) |
6.7%
Caution
↑
Caution
Improving
Return earned on debt + equity capital invested
Optimal:
> 10%
|
3.3%
Weak
↓
Weak
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— |
1.5%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
7.3%
Fair
Fair
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — |
| Return on Capital (%) (%) |
3.2%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
3.2%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — | — | — |
| Return on Common Equity (%) (%) |
4.4%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-45%)
|
4.7%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-41%)
|
— |
8.5%
Caution
Caution
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+6%)
|
8.7%
Caution
Caution
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+8%)
|
— | — |
| Metric | Q2 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Dec 31, 2025 10-Q ↗ | Q4 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2024 10-Q ↗ | Q4 FY2024 Sep 30, 2024 10-K ↗ | Q4 FY2023 Sep 30, 2023 10-K ↗ |
|---|---|---|---|---|---|---|---|
| Interest Coverage (x) | — | — | — |
1.81x
Caution
Caution
Operating income divided by interest expense
Optimal:
> 5x
|
13.86x
Excellent
Excellent
Operating income divided by interest expense
Optimal:
> 5x
|
— | — |
| Metric | Q2 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Dec 31, 2025 10-Q ↗ | Q4 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2024 10-Q ↗ | Q4 FY2024 Sep 30, 2024 10-K ↗ | Q4 FY2023 Sep 30, 2023 10-K ↗ |
|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $4.00M | $1.15M | $1.19M | — | — | $1.70M | — |
| Total Equity (USD) | $2.14M | $2.00M | $1.92M | $1.34M | $1.31M | $1.18M | $340.84K |
| Metric | Q2 FY2026 Mar 31, 2026 10-Q ↗ | Q1 FY2026 Dec 31, 2025 10-Q ↗ | Q4 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Mar 31, 2025 10-Q ↗ | Q1 FY2025 Dec 31, 2024 10-Q ↗ | Q4 FY2024 Sep 30, 2024 10-K ↗ | Q4 FY2023 Sep 30, 2023 10-K ↗ |
|---|---|---|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $778.95K | $483.24K | — | $378.32K | $429.87K | — | — |
| Net Income, GAAP (USD) | $94.71K | $94.71K | — | $113.33K | $113.33K | — | — |
| Operating Cash Flow (USD) | $-113.62K | $-157.39K | — | $-92.70K | $221.50K | — | — |
Secondary lens
Benchmark Lens
Compare CLBZ against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare CLBZ against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for CLBZ
No bullish signals detected
Operating Margin (%) is in the bottom quartile
Profit Margin (%) is in the bottom quartile
Percentile Rankings
How CLBZ compares to all companies
Peer Comparison
CLBZ vs similar peers
Compare CLBZ with peers
Stack CLBZ against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 3 years · 7 quarters